Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Exercise in pregnancy shows promise for overweight moms

NCT ID NCT02582567

Disease control Sponsor: Universidad de Granada Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a supervised exercise program (3 times a week) could improve health for overweight pregnant women and their newborns. 140 women were randomly assigned to either the exercise group or a usual-care group. Researchers measured things like weight gain, blood sugar levels, and overall health markers in both mothers and babies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

140 people

The number who actually took part.

Started

Oct 2015

Finished

Jul 2018

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 40 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Overweight pregnant woman with a normal pregnancy course. * Answer "no" to all questions on the PARmed-X for pregnancy\*. * To be able to walk without assistance. * To be able to read and write enough. * Informed consent: To be capable and willing to provide consent. \*In addition, specific inclusion criteria for data analysis are: gestational age at delivery of 37-42 weeks with single foetus, spontaneous vaginal delivery or instrumental vaginal and caesarean without maternofoetal pathology (or other indication that does not involve maternofoetal risk, such as disproportion, failed induction, no foetal progression or non-cephalic presentation), newborn with appropriate weight, Apgar score\>7 in the 1st and 5th minute of life, cord blood pH (normal\>7.20) and normal monitoring results. Exclusion criteria: * Acute or terminal illness. * Malnutrition. * Inability to conduct tests for assessing physical fitness or exercise during pregnancy. * Underweight, normal-weight or obesity. * Pregnancy risk factors (such as hypertension, type 2 diabetes, etc.). * Multiple pregnancies. * Chromosopathy or foetal malformations. * Uterine growth restriction. * Foetal death. * Upper or lower extremity fracture in the past 3 months. * Presence of neuromuscular disease or drugs affecting neuromuscular function * Be registered in other exercise program * Perform more than 300 minutes of at least moderate physical activity per week * Unwillingness to either complete the study requirements or to be randomised into control or intervention group.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Inflammation Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pregnancy

Contacts and locations

Locations

  • Pilar Cabello-Turmo

    Granada, Granada, 18071, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.